Exercise in Men Receiving Radiation Therapy for Prostate Cancer.

NCT ID: NCT00253916

Last Updated: 2020-04-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

121 participants

Study Classification

INTERVENTIONAL

Study Start Date

2002-06-30

Study Completion Date

2009-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Androgen Deprivation Therapy is a commonly used treatment for men with Prostate Cancer. Unfortunately this can lead to functional decline, fatigue, increased body fatness, loss of lean body tissue and impaired QOL. Previous research has demonstrated the exercise can may reduce fatigue and improve QOL in men on ADT. This study will evaluate whether aerobic versus resistance exercise over a 24 week period of training will reduce morbidity and improve QOL in men receiving radiation plus or minus ADT with curative intent

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A total of 220 men with a diagnosis of prostate cancer, scheduled to receive radiation will be recruited. The study is a parallel 3-group design with groups stratified for intended duration of ADT ( greater or less than 12 weeks) and random assignment to aerobic, resistance or Wait List control groups. The dependent variable of interest will fatigue measured at 24 weeks by the 13 item FACT-Fatigue. Dependent variables of secondary interest will be toxicity of radiation, body composition, muscular fitness, cardio-respiratory fitness, metabolic fitness, and prostate specific QOL. All exercise sessions will be performed 3 times per week at the Ottawa Hospital regional Cancer Center

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prostatic Neoplasms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Arm

No exercise measured

Group Type NO_INTERVENTION

No interventions assigned to this group

Aerobic cardiovascular exercise program

Aerobic cardiovascular exercise program

Group Type EXPERIMENTAL

Aerobic cardiovascular exercise program

Intervention Type BEHAVIORAL

Aerobic cardiovascular exercise program

Resistance Exercise Program

Resistance Exercise Program

Group Type EXPERIMENTAL

Resistance Exercise Program

Intervention Type BEHAVIORAL

Resistance Exercise Program

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Aerobic cardiovascular exercise program

Aerobic cardiovascular exercise program

Intervention Type BEHAVIORAL

Resistance Exercise Program

Resistance Exercise Program

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Prostate Cancer
* Radiation Therapy with curative Intent
* ADT

Exclusion Criteria

* Contraindication to exercise
* Uncontrolled hypertension
* Uncontrolled Cardiac Disease
* Uncontrolled psychotic condition
* Unable to obtain informed consent
Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Canadian Cancer Trials Group

NETWORK

Sponsor Role collaborator

Ottawa Hospital Research Institute

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Roanne Segal

Role: PRINCIPAL_INVESTIGATOR

OHRI

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Ottawa Hospital-Integrated Cancer Program

Ottawa, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

References

Explore related publications, articles, or registry entries linked to this study.

Segal RJ, Reid RD, Courneya KS, Malone SC, Parliament MB, Scott CG, Venner PM, Quinney HA, Jones LW, D'Angelo ME, Wells GA. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol. 2003 May 1;21(9):1653-9. doi: 10.1200/JCO.2003.09.534.

Reference Type RESULT
PMID: 12721238 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OTT 02-04

Identifier Type: OTHER

Identifier Source: secondary_id

CERHO 2002263-01H

Identifier Type: OTHER

Identifier Source: secondary_id

NCIC 013232

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

ADT Exercise Trial and Economic Analysis
NCT02834416 COMPLETED PHASE3